Resumen
Introduction: Helicobacter pylori is a highly prevalent bacterium in the Guatemalan population. It is known for causing a wide variety of gastrointestinal disease but has been related to systemic inflammatory conditions that could trigger pathophysiological processes in other organ systems such as the cardiovascular system. In this study we focus on the coexistence of the bacteria and acute coronary syndrome. Objective: To identify the presence of Helicobacter pylori infestation in patients who consulted a public hospital for diagnosis and management of acute coronary syndrome. Methodology: A descriptive cross-sectional study was carried out. A total of 50 patients admitted to the Cardiology Unit with a diagnosis of acute coronary syndrome were included, they were tested for Helicobacter pylori fecal antigen in feces. Results: Of all the patients with acute coronary syndrome, 68% were male; 52% suffer from arterial hypertension, and 50% have type 2 diabetes mellitus. 54% of patients with acute coronary syndrome were infected by H. pylori. Conclusion: The study showed an increased rate of infection by H. pylori in patients diagnosed with an ACS, however, it was not possible to determine an attributable increase in risk or causality.
Citas
McColl, K.E.L. Helicobacter pylori Infection. New England Journal of Medicine. Clinical Practice, 2010, April; 362(17): 1597-1604. https://doi.org/10.1056/NEJMcp1001110
Fang, Y., Fan, C., & Xie, H. Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: A systematic review and meta-analysis. Medicine, 2019, Dec.; 98(50):p; e18348. https://doi.org/10.1097/MD.0000000000018348
Wong, F., Rayner-Hartley, E., & Byrne, M.F. Extraintestinal manifestations of Helicobacter pylori : A concise review. World Journal of Gastroenterology, 2014, Sept.; 20(34): 11950-11961. https://doi.org/10.3748/wjg.v20.i34.11950
O’Gara, P.T., Kushner, F.G., Ascheim, D.D., Casey Jr., D.E., Chung, M.K., De Lemos, J.A., Ettinger, S.M., Fang, J.C., Fesmire, F.M., Franklin, B.A., Granger, C.B., Krumholz, H.M., Linderbaum, J.A., Morrow, D.A., Newby, L.K., Ornato, J.P., Ou, N., Radford, M.J., Tamis-Holland, J.E., Tommaso, C.L., Tracy, C.M., Woo, Y.J., Zhao, D.X. 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013, January; 127(4): e362-425. https://doi.org/10.1161/CIR.0b013e3182742cf6
Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E., Ganiats, T.G., Holmes Jr., D.R., Jaffe, A.S., Jneid, H., Kelly, Rosemary F., Kontos, M.C., Levine, G.N., Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W., Zieman, S.J. 2014 AHA/ACC Guideline for the management of patients with Non–ST-elevation Acute Coronary Syndromes : a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Journal of the American College of Cardiology, 2014, Dec.; 64(24): 2713-2714. https://doi.org/10.1016/j.jacc.2014.09.017
Jamkhande, P.G., Gattani, S.G., & Farhat, S.A. Helicobacter pylori and cardiovascular complications : a mechanism based review on role of Helicobacter pylori in cardiovascular diseases. Integrative medicine research, 2016, December; 5(4): 244–249. https://doi.org/10.1016/j.imr.2016.05.005
Longo-Mbenza, B., Nkondi Nsenga, J., & Vangu Ngoma, D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. International Journal of Cardiology, 2007, October; 121(3): 229–238. https://doi.org/10.1016/j.ijcard.2006.12.003
Liu, J., Wang, F., & Shi, S. Helicobacter pylori Infection Increase the Risk of Myocardial Infarction: A Meta-Analysis of 26 Studies Involving more than 20,000 Participants. Helicobacter, 2014, June; 20(3): 176–183. https://doi.org/10.1111/hel.12188
Wärme, J., Sundqvist, M., Mars, K., Aladellie, L., Pawelzik, S.C., Erlinge, D., Jernberg, T., James, S., Hofman, R., Bäck, M. Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction. American Heart Journal, 2021, January; 231: 105-109. https://doi.org/10.1016/j.ahj.2020.10.072
World Health Organization. The top 10 causes of death. Newsroom, Factsheets. 2020, December. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Vos, T., Lim, S.S., Abbafati, C., Abbas, K.M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abolhassani, H., Aboyans, V., Abrams, E. M., Abreu, L. G., Abrigo, M. R. M., Abu-Raddad, L. J., Abushouk, A. I., Murray, C. J. L. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 2020, October; 396(10258): 1204–1222. https://doi.org/10.1016/s0140-6736(20)30925-9
Díaz, Y.A., De León, J.L., Rivera, L.E., & Matta, V.L. Prevalencia de la infección por Helicobacter pylori en la población que asistió a las clínicas de APROFAM durante 2006-2011. Ciencia, Tecnología Y Salud, 2017, diciembre; 4(2): 217-226. https://doi.org/10.36829/63CTS.v4i2.235
Sun, J., Rangan, P., Bhat, S.S., & Liu, L. A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies. Helicobacter, 2016, May; 21(1): 11-23. https://doi.org/10.1111/hel.12234
Franceschi, F., Niccoli, G., Ferrante, G., Gasbarrini, A., Baldi, A., Candelli, M., Feroce, F., Saulnier, N., Conte, M, Roccarina, D., Lanza, G.A., Gasbarrini, G., Gentiloni, S.N., Crea, F. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis, 2009, February; 202(2): 535-542. https://doi.org/10.1016/j.atherosclerosis.2008.04.051
Wang, B., Yu, M., Zhang, R., Chen, S., Xi, Y., & Duan, G. A meta‐analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease. Helicobacter, 2020, October; 25(6): e12761. https://doi.org/10.1111/hel.12761
Rahmani, Y., Mohammadi, S., Babanejad, M., Rai, A., Zalei, B., & Shahmohammadi, A. Association of Helicobacter pylori with Presence of Myocardial Infarction in Iran: A Systematic Review and Meta-Analysis. Ethiopian Journal of Health Sciences, 2017, July; 27(4), 433-440. https://doi.org/10.4314/ejhs.v27i4.15
Weber, T., Lang, I., Zweiker, R., Horn, S., Wenzel, R. R., Watschinger, B., Slany, J., Eber, B., Roithinger, F. X., & Metzler, B. Hypertension and coronary artery disease: Epidemiology, physiology, effects of treatment, and recommendations. Wiener Klinische Wochenschrift, 2016, June; 128(13-14): 467–479. https://doi.org/10.1007/s00508-016-0998-5
Aronson, D., & Edelman, E.R. Coronary artery disease and diabetes mellitus. Cardiology Clinics, 2014, August; 32(3): 439–455. https://doi.org/10.1016/j.ccl.2014.04.001
Katta, N., Loethen, T., Lavie, C.J., & Alpert, M.A. Obesity and coronary heart disease: Epidemiology, pathology, and coronary artery imaging. Current Problems in Cardiology, 2021, March; 46(3): 100655. https://doi.org/10.1016/j.cpcardiol.2020.100655
Nasser, N.J., Fox, J., & Agbarya, A. Potential mechanisms of cancer-related hypercoagulability. Cancers, 2020, February; 12(3): 566. https://doi.org/10.3390/cancers12030566
Copyright
© 2022 Juan Pablo Cóbar Ligorría, Markus Gerhard Feucht Archila y Luis Rodríguez
